INCY vs JNJ Stock Comparison
INCY currently leads JNJ in this stock comparison, with AIQ scores of 64 vs 51. The clearest difference is risk resilience, while JNJ has the stronger momentum profile.
What is the main difference between INCY and JNJ?
INCY leads the current stock comparison as Incyte Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Incyte Corporation vs Johnson & Johnson
INCY leads
INCY leads by 13 AIQ points, primarily on Risk Resilience and Quality, and the lead has widened from 7 points over 30 sessions.
Stable: 4 of 6 evidence groups support INCY, its lead is widening, and its signal state is cleanly positive.
Incyte Corporation
Johnson & Johnson
The Algovestiq AIQ Score currently favors INCY over JNJ, 64 versus 51 as of Oct 21, 2026. INCY's advantage is driven primarily by stronger risk resilience and quality, while JNJ holds the stronger momentum profile. INCY also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor INCY today, and the comparison is rated Stable on stability. INCY lead: Strengthening — the AIQ differential moved from 7 to 13 points over 30 sessions.
Compare Incyte Corporation and Johnson & Johnson across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare INCY and JNJ against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience74 vs 48INCY +26
- Quality90 vs 71INCY +19
- Value52 vs 39INCY +13
- Momentum40 vs 44JNJ +4
4 of 6 evidence groups favor INCY. INCY’s edge is concentrated in risk resilience and quality; JNJ keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +10
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
Largest factor move: Momentum +8
No signal started or stopped since the prior session; its 2 active signals are unchanged.
INCY's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — INCY and JNJ both carry a full feed there.
The central trade-off
INCY (Incyte Corporation): the stronger current systematic profile, led by risk resilience and quality.
JNJ (Johnson & Johnson): the counter-case, on momentum.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
INCYINCY on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
INCYINCY on combined revenue and EPS growth.
Value
INCYINCY on the peer-relative Value factor, by 13 points.
Momentum
JNJJNJ on the Momentum factor, by 4 points.
Lower downside
INCYINCY on Risk Resilience, by 26 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | INCY | JNJ | Note |
|---|---|---|---|
| Implied upside to target | +9.9% | +9.4% | Level |
| Target dispersion | +53.7% | +21.3% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 15 | 15 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor INCY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | INCY | 64 vs 51 |
| Fundamentals | INCY | EPS growth 92.1% vs -96.2%; TTM ROE 29.7% vs 19.7%; gross margin 92.6% vs 68.8%; operating margin 31.6% vs 25.7% |
| Valuation | INCY | Value 52 vs 39 |
| Technicals | Even | Price vs 50-day -6.7% vs -2.8%; vs 200-day 8.3% vs 6% |
| Risk Resilience | INCY | Risk Resilience 74 vs 48 |
| Analyst expectations | Even | Target upside 9.9% vs 9.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of INCY and JNJ and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 13 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INCY.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20INCY lead: Strengthening — the AIQ differential moved from 7 to 13 points over 30 sessions.
- Today
- INCY +13
- 64 vs 51
- 7 sessions ago
- INCY +12
- 61 vs 49
- 30 sessions ago
- INCY +7
- 64 vs 57
- 90 sessions ago
- INCY +9
- 65 vs 56
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish
Only INCY
- MACD Bullish Crossover — bullish, momentum, short horizon
1 bullish / 1 bearish, conflicted
Only JNJ
- MACD Bearish Crossover — bearish, momentum, short horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
JNJ is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -2.72%, AIQ +3 points).
Price is down while the AIQ Score moved up 2 points over the same session — price and model disagree (price -0.61%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JNJ closes the Risk Resilience gap — currently 26 points behind, the largest single contributor to INCY's edge.
- 2JNJ's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it.
- 3INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
INCY leads on balance| Metric | INCY | JNJ |
|---|---|---|
| Revenue growth (YoY) | 31.5% | 0.4% |
| EPS growth (YoY) | 92.1% | -96.2% |
| Gross margin | 92.6% | 68.8% |
| Operating margin | 31.6% | 25.7% |
| Return on equity (TTM) | 29.7% | 19.7% |
| Debt to equity | 0.01 | 0.58 |
Performance
JNJ leads 4 of 6 windows| Metric | INCY | JNJ |
|---|---|---|
| 1 week (5 sessions) | 7.4% | 4.3% |
| 1 month (20 sessions) | -8.1% | -3.7% |
| 3 months (63 sessions) | 0.7% | 1.5% |
| 6 months (126 sessions) | 21.2% | 14.7% |
| Year to date | 18.1% | 25.3% |
| 1 year (252 sessions) | 33.6% | 35% |
Technicals
Split| Metric | INCY | JNJ |
|---|---|---|
| RSI (14) | 39.5 | 45.3 |
| ADX (14) | 25.2 | 15.1 |
| Price vs 50-day | -6.7% | -2.8% |
| Price vs 200-day | 8.3% | 6% |
| Volatility (1M, annualized) | 25.4% | 28.8% |
Risk
INCY is the more resilient| Metric | INCY | JNJ |
|---|---|---|
| Beta | 0.4 | -0.21 |
| Sharpe ratio | 0.91 | 1.36 |
| Sortino ratio | 1.55 | 2.03 |
| Max drawdown | -18.3% | -11% |
| Current drawdown | -10.3% | -6.8% |
| Annualized volatility | 33.4% | 20.4% |
| Value at risk (95%) | -2.7% | -1.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, INCY or JNJ?
On the Algovestiq AIQ Score, INCY is the stronger of the two as of Oct 21, 2026, scoring 64 against JNJ's 51. The edge comes from risk resilience and quality. JNJ is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is INCY or JNJ the better buy right now?
INCY carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor INCY over JNJ?
The composite weights Quality, Value, Momentum and Risk Resilience. INCY leads Risk Resilience by 26 points; INCY leads Quality by 19 points; INCY leads Value by 13 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, INCY or JNJ?
Analyst price targets imply +9.9% upside for INCY and +9.4% for JNJ. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, INCY or JNJ?
INCY is the better-valued of the two on the peer-relative Value factor. INCY on the peer-relative Value factor, by 13 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, INCY or JNJ?
INCY on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, INCY or JNJ?
JNJ on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, INCY or JNJ?
INCY is the more resilient of the two, so the other name carries the higher downside risk. INCY on Risk Resilience, by 26 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is INCY more profitable than JNJ?
INCY leads on the comparable margin measures — gross margin 92.6% vs 68.8%; operating margin 31.6% vs 25.7%; ttm roe 29.7% vs 19.7%.
Is INCY's lead over JNJ getting stronger or weaker?
INCY lead: Strengthening — the AIQ differential moved from 7 to 13 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.
What would change the INCY vs JNJ verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JNJ closes the Risk Resilience gap — currently 26 points behind, the largest single contributor to INCY's edge; JNJ's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it; INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about INCY and JNJ?
INCY: 2 bullish / 0 bearish. JNJ: 1 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on INCY is Golden Cross Active (bullish, long horizon). On JNJ it is Golden Cross Active (bullish, long horizon).
Compare INCY and JNJ with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.